Review



rabbit anti human il 22r antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems rabbit anti human il 22r antibody
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Rabbit Anti Human Il 22r Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+Antibody/pmc05752511-181-6-11
    Average 94 stars, based on 12 article reviews
    rabbit anti human il 22r antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Interleukin-22 participates in the inflammatory process of vitiligo"

    Article Title: Interleukin-22 participates in the inflammatory process of vitiligo

    Journal: Oncotarget

    doi: 10.18632/oncotarget.22644

    (A) To block IL-22R-mediated signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Figure Legend Snippet: (A) To block IL-22R-mediated signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.

    Techniques Used: Blocking Assay, Expressing, Enzyme-linked Immunosorbent Assay, Transfection, Control, Knockdown, Negative Control

    Related Articles

    Expressing:

    Article Title: IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway.
    Article Snippet: IL-1b positive areas were normalized through calculation of pixel density using Image Analysis Software (analySIS FIVE; Olympus Corporation, Tokyo, Japan). .. To analyze the expression of the IL-17RA1 and IL-22R cell surface receptors, HaCaT cells were stained with anti-human IL-17RA1 (Rb07, mouse monoclonal IgG1; Santa Cruz Biotechnology) and anti-human IL-22R (FAB2770P; R&D systems). ..

    Staining:

    Article Title: IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway.
    Article Snippet: IL-1b positive areas were normalized through calculation of pixel density using Image Analysis Software (analySIS FIVE; Olympus Corporation, Tokyo, Japan). .. To analyze the expression of the IL-17RA1 and IL-22R cell surface receptors, HaCaT cells were stained with anti-human IL-17RA1 (Rb07, mouse monoclonal IgG1; Santa Cruz Biotechnology) and anti-human IL-22R (FAB2770P; R&D systems). ..



    Similar Products

    94
    R&D Systems rabbit anti human il 22r antibody
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Rabbit Anti Human Il 22r Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+Antibody/pmc05752511-181-6-11
    Average 94 stars, based on 1 article reviews
    rabbit anti human il 22r antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    R&D Systems anti human il 22r apc
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Anti Human Il 22r Apc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+APC-conjugated+Antibody/pm25510212-33-16-18
    Average 90 stars, based on 1 article reviews
    anti human il 22r apc - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    94
    R&D Systems monoclonal anti human il 22r allophycocyanin
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Monoclonal Anti Human Il 22r Allophycocyanin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+Antibody/pm25510212-27-4-15
    Average 94 stars, based on 1 article reviews
    monoclonal anti human il 22r allophycocyanin - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti-human il-22r
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Goat Anti Human Il 22r, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+Antibody/pm24126111-69-6-18
    Average 94 stars, based on 1 article reviews
    goat anti-human il-22r - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    ProSci Incorporated rabbit anti human il 22r
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Rabbit Anti Human Il 22r, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/IL22+Antibody/pm24056519-91-12-16
    Average 90 stars, based on 1 article reviews
    rabbit anti human il 22r - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    93
    R&D Systems anti human il 22r
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Anti Human Il 22r, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+PE-conjugated+Antibody/pm22207130-79-27-30
    Average 93 stars, based on 1 article reviews
    anti human il 22r - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti human il 22r ab
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Goat Anti Human Il 22r Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+Antibody/pm21345484-279-30-34
    Average 94 stars, based on 1 article reviews
    goat anti human il 22r ab - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    91
    R&D Systems anti il 22r antibody 7e9
    (A) To block <t>IL-22R-mediated</t> signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.
    Anti Il 22r Antibody 7e9, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-10+R+beta+PE-conjugated+Antibody/us07737259-1862-27-36
    Average 91 stars, based on 1 article reviews
    anti il 22r antibody 7e9 - by Bioz Stars, 2026-09
    91/100 stars
      Buy from Supplier

    94
    R&D Systems goat anti il 22r antibody
    Figure 3. IL-20R1, IL-20R2, <t>IL-22R,</t> and IL-10R2 expression in cultured epidermal keratinocytes. (A) Normal epidermis was obtained from nine subjects and cultured keratinocytes were from eight other normal subjects. IL-20R1, IL-20R2, IL-22R, and IL-10R2 expression levels were determined by real-time RT-PCR, with cyclophilin as house keeping control, and compared between normal epidermis (black bar) and cultured keratinocytes (gray bar). Data show mean7SD. po0.05; po0.001. (B) Western blot analysis of IL-20R1, IL-20R2, and IL-22R protein expression in cultured keratinocytes. (C) IL-22R expression levels were analyzed by flow cytometry (isotype control Ab: shaded area; anti-IL-22R Ab: thin line). Infection of AxIL22R at an MOI of 5 for 48 h increased IL-22R expression in keratinocytes (thick line), but not AxLacZ (dotted line). Data are representative of two independent experiments. (D) Uninfected control cultures or keratinocytes infected with AxIL22R were treated with 10 ng/mL IL-19, IL-20, IL-24, and IL-22. STAT-3 phosphorylation at 15 min or 24 h after stimulation was determined by Western blot. Data are representative of three independent experiments.
    Goat Anti Il 22r Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+human+il+22r/Human+IL-22+R+alpha+1+Antibody/pm19731362-182-26-30
    Average 94 stars, based on 1 article reviews
    goat anti il 22r antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    (A) To block IL-22R-mediated signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.

    Journal: Oncotarget

    Article Title: Interleukin-22 participates in the inflammatory process of vitiligo

    doi: 10.18632/oncotarget.22644

    Figure Lengend Snippet: (A) To block IL-22R-mediated signaling, pre-treatment of HaCaT cells with 50 μg/ml of anti-IL-22R blocking antibody for 2 h prior to IL-22 stimulation resulted in reduced NLRP3 and caspase-1 expression (B) as well as a consequent reduction in IL-1β secretion as measured by ELISA. (C) To reduce NLRP3 expression in HaCaT cells, we transfected NLRP3 siRNA or control siRNA into HaCaT cells. The level of protein was quantified to evaluate the knockdown efficiency of the endogenous NLRP3 protein in HaCaT cells. Data from three independent experiments for protein expression are shown. (D) The active form of IL-1β in culture supernatants was quantitated by ELISA. (E) NLRP3 knockdown in HaCaT cells resulted in a reduction in the levels of caspase-1 and the active form of IL-1β in IL-22-treated cells. Representative blots of three independent experiments are shown. Results were normalized against β-actin expression. The data are expressed as means ± SD (i.e. n=3) ( ** P < 0.05). Ab, anti-IL-22R blocking antibody; IgG, isotype antibody for the negative control of IL-22R antibody.

    Article Snippet: The cells were pretreated with either rabbit anti-human IL-22R antibody (AF2770; R&D systems) or with the isotype control (AB-108-C; R&D systems) at a concentration of 50 μg/ml for 2 h to block IL-22R in HaCaT cells.

    Techniques: Blocking Assay, Expressing, Enzyme-linked Immunosorbent Assay, Transfection, Control, Knockdown, Negative Control

    Figure 3. IL-20R1, IL-20R2, IL-22R, and IL-10R2 expression in cultured epidermal keratinocytes. (A) Normal epidermis was obtained from nine subjects and cultured keratinocytes were from eight other normal subjects. IL-20R1, IL-20R2, IL-22R, and IL-10R2 expression levels were determined by real-time RT-PCR, with cyclophilin as house keeping control, and compared between normal epidermis (black bar) and cultured keratinocytes (gray bar). Data show mean7SD. po0.05; po0.001. (B) Western blot analysis of IL-20R1, IL-20R2, and IL-22R protein expression in cultured keratinocytes. (C) IL-22R expression levels were analyzed by flow cytometry (isotype control Ab: shaded area; anti-IL-22R Ab: thin line). Infection of AxIL22R at an MOI of 5 for 48 h increased IL-22R expression in keratinocytes (thick line), but not AxLacZ (dotted line). Data are representative of two independent experiments. (D) Uninfected control cultures or keratinocytes infected with AxIL22R were treated with 10 ng/mL IL-19, IL-20, IL-24, and IL-22. STAT-3 phosphorylation at 15 min or 24 h after stimulation was determined by Western blot. Data are representative of three independent experiments.

    Journal: European journal of immunology

    Article Title: IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.

    doi: 10.1002/eji.200939473

    Figure Lengend Snippet: Figure 3. IL-20R1, IL-20R2, IL-22R, and IL-10R2 expression in cultured epidermal keratinocytes. (A) Normal epidermis was obtained from nine subjects and cultured keratinocytes were from eight other normal subjects. IL-20R1, IL-20R2, IL-22R, and IL-10R2 expression levels were determined by real-time RT-PCR, with cyclophilin as house keeping control, and compared between normal epidermis (black bar) and cultured keratinocytes (gray bar). Data show mean7SD. po0.05; po0.001. (B) Western blot analysis of IL-20R1, IL-20R2, and IL-22R protein expression in cultured keratinocytes. (C) IL-22R expression levels were analyzed by flow cytometry (isotype control Ab: shaded area; anti-IL-22R Ab: thin line). Infection of AxIL22R at an MOI of 5 for 48 h increased IL-22R expression in keratinocytes (thick line), but not AxLacZ (dotted line). Data are representative of two independent experiments. (D) Uninfected control cultures or keratinocytes infected with AxIL22R were treated with 10 ng/mL IL-19, IL-20, IL-24, and IL-22. STAT-3 phosphorylation at 15 min or 24 h after stimulation was determined by Western blot. Data are representative of three independent experiments.

    Article Snippet: The following primary antibodies were used: goat anti-IL-19 antibody (AF1035, R&D Systems), mouse anti-IL-20 antibody (Abcam, Tokyo, Japan), mouse anti-IL-24 antibody (MAB 19651, R&D Systems), and goat anti-IL-22R antibody (AF2770, R&D Systems).

    Techniques: Expressing, Cell Culture, Quantitative RT-PCR, Control, Western Blot, Cytometry, Infection, Phospho-proteomics

    Figure 6. IL-22R expression in the epidermis of normal and psoriatic skin. (A) Total RNA was extracted from the epidermis of nine normal and 11 psoriatic skin samples. IL-20R1, IL-20R2, IL-22R, and IL-10R2 mRNA expression levels were determined by real-time RT-PCR, with cyclophilin as house keeping control. Results were expressed as relative expression levels of mRNA (gray bar) compared with that in normal epidermis (black bar). Data show mean7SD.po0.05. (B) IL-22R immunostaining of four normal and six psoriatic skin samples. In four psoriatic skin samples, fluorescence intensity increased markedly as a result of IL-22R over-expression. Scale bar, 50 mm.

    Journal: European journal of immunology

    Article Title: IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.

    doi: 10.1002/eji.200939473

    Figure Lengend Snippet: Figure 6. IL-22R expression in the epidermis of normal and psoriatic skin. (A) Total RNA was extracted from the epidermis of nine normal and 11 psoriatic skin samples. IL-20R1, IL-20R2, IL-22R, and IL-10R2 mRNA expression levels were determined by real-time RT-PCR, with cyclophilin as house keeping control. Results were expressed as relative expression levels of mRNA (gray bar) compared with that in normal epidermis (black bar). Data show mean7SD.po0.05. (B) IL-22R immunostaining of four normal and six psoriatic skin samples. In four psoriatic skin samples, fluorescence intensity increased markedly as a result of IL-22R over-expression. Scale bar, 50 mm.

    Article Snippet: The following primary antibodies were used: goat anti-IL-19 antibody (AF1035, R&D Systems), mouse anti-IL-20 antibody (Abcam, Tokyo, Japan), mouse anti-IL-24 antibody (MAB 19651, R&D Systems), and goat anti-IL-22R antibody (AF2770, R&D Systems).

    Techniques: Expressing, Quantitative RT-PCR, Control, Immunostaining, Over Expression

    Figure 7. Effect of IL-20, IL-24, and IL-22 on cytokine production. (A) Cultured keratinocytes transduced with (black bar) or without (gray bar) IL-22R by an adenovirus vector were treated for 36 h with IL-20 (10 ng/mL), IL-24 (10 ng/mL), or IL-22 (10 ng/mL) in combination with or without IL-17 (10 ng/mL). The levels of mRNA expression were corrected using cyclophilin expression relative to the untreated cells (control) level. (B) Cultured keratinocytes transduced with IL-22R by an adenovirus vector were treated with IL-20 (10 ng/mL), IL-24 (10 ng/mL), or IL-22 (10 ng/mL) for 48 h in combination with (10 ng/mL) or without IL-17. Culture media were collected, and MIP-3a and HB-EGF were measured by ELISA. The analysis was performed in triplicate. Data show mean7SD. Data are representative of three independent experiments. po0.05; po0.01.

    Journal: European journal of immunology

    Article Title: IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.

    doi: 10.1002/eji.200939473

    Figure Lengend Snippet: Figure 7. Effect of IL-20, IL-24, and IL-22 on cytokine production. (A) Cultured keratinocytes transduced with (black bar) or without (gray bar) IL-22R by an adenovirus vector were treated for 36 h with IL-20 (10 ng/mL), IL-24 (10 ng/mL), or IL-22 (10 ng/mL) in combination with or without IL-17 (10 ng/mL). The levels of mRNA expression were corrected using cyclophilin expression relative to the untreated cells (control) level. (B) Cultured keratinocytes transduced with IL-22R by an adenovirus vector were treated with IL-20 (10 ng/mL), IL-24 (10 ng/mL), or IL-22 (10 ng/mL) for 48 h in combination with (10 ng/mL) or without IL-17. Culture media were collected, and MIP-3a and HB-EGF were measured by ELISA. The analysis was performed in triplicate. Data show mean7SD. Data are representative of three independent experiments. po0.05; po0.01.

    Article Snippet: The following primary antibodies were used: goat anti-IL-19 antibody (AF1035, R&D Systems), mouse anti-IL-20 antibody (Abcam, Tokyo, Japan), mouse anti-IL-24 antibody (MAB 19651, R&D Systems), and goat anti-IL-22R antibody (AF2770, R&D Systems).

    Techniques: Cell Culture, Transduction, Plasmid Preparation, Expressing, Control, Enzyme-linked Immunosorbent Assay

    Figure 8. Role of IL-22R and the IL-20 subfamily in psoriasis. In psoriatic skin, IL-22R expression in the epidermis is elevated compared with normal skin. IL-22 and IL-17 produced by Th17 lymphocytes induce abundant expression of the IL-20 subfamily and chemokines such as MIP-3a and IL-8, and HB-EGF compared with normal skin. MIP- 3a and IL-8 recruit further Th17 lymphocytes and neutrophils, respectively. HB-EGF may induce epidermal hyperproliferation. Surrounding keratinocytes treated with IL-20 and IL-24 strongly responded to IL-17 and produced more MIP-3a, IL-8, and HB-EGF. Phosphorylation of STAT3 was observed in the nuclei of keratinocytes stimulated with IL-22 or IL-20 subfamily members.

    Journal: European journal of immunology

    Article Title: IL-17 and IL-22 mediate IL-20 subfamily cytokine production in cultured keratinocytes via increased IL-22 receptor expression.

    doi: 10.1002/eji.200939473

    Figure Lengend Snippet: Figure 8. Role of IL-22R and the IL-20 subfamily in psoriasis. In psoriatic skin, IL-22R expression in the epidermis is elevated compared with normal skin. IL-22 and IL-17 produced by Th17 lymphocytes induce abundant expression of the IL-20 subfamily and chemokines such as MIP-3a and IL-8, and HB-EGF compared with normal skin. MIP- 3a and IL-8 recruit further Th17 lymphocytes and neutrophils, respectively. HB-EGF may induce epidermal hyperproliferation. Surrounding keratinocytes treated with IL-20 and IL-24 strongly responded to IL-17 and produced more MIP-3a, IL-8, and HB-EGF. Phosphorylation of STAT3 was observed in the nuclei of keratinocytes stimulated with IL-22 or IL-20 subfamily members.

    Article Snippet: The following primary antibodies were used: goat anti-IL-19 antibody (AF1035, R&D Systems), mouse anti-IL-20 antibody (Abcam, Tokyo, Japan), mouse anti-IL-24 antibody (MAB 19651, R&D Systems), and goat anti-IL-22R antibody (AF2770, R&D Systems).

    Techniques: Expressing, Produced, Phospho-proteomics